Novel Therapy for Transthyretin-related Ocular Amyloidosis. A Pilot Study of Retinal Laser Photocoagulation

Ophthalmology

Volumn 117, Issue 3, 2010, Pages 552-555

  Kawaji, Takahiro ^a   Ando, Yukio ^a   Hara, Ryuhei ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; MITOMYCIN C; PREALBUMIN;

ADULT; AMYLOIDOSIS; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; EYE; EYE DISEASE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENETIC ANALYSIS; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LIVER TRANSPLANTATION; MALE; NEUROLOGIC EXAMINATION; OCULAR AMYLOIDOSIS; OPHTHALMOLOGY; OPHTHALMOSCOPY; PANRETINAL LASER PHOTOCOAGULATION; PATIENT SAFETY; PIGMENT EPITHELIUM; PILOT STUDY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRABECULECTOMY; VISUAL ACUITY; VITREOUS BODY; VITREOUS OPACITY;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; MIDDLE AGED; PILOT PROJECTS; PREALBUMIN; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; VISUAL ACUITY; VITREOUS BODY;

EID: 77049106558     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.07.042     Document Type: Article

References (20)

1. Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 6 (1984) 128-133
2. Ando Y., Nakamura M., and Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62 (2005) 1057-1062
3. Holmgren G., Ericzon B.G., Groth C.G., et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341 (1993) 1113-1116
4. Ando Y., Tanaka Y., Ando E., et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I [letter]. Lancet 345 (1995) 195-196
5. Ando E., Ando Y., and Haraoka K. Ocular amyloid involvement after liver transplantation for polyneuropathy [letter]. Ann Intern Med 135 (2001) 931-932
6. Sandgren O., Kjellgren D., and Suhr O.B. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 86 (2008) 520-524
7. Cavallaro T., Martone R.L., Dwork A.J., et al. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 31 (1990) 497-501
8. Kawaji T., Ando Y., Nakamura M., et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 81 (2005) 306-312
9. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 40 (1995) 173-196
10. Ando E., Ando Y., Okamura R., et al. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 81 (1997) 295-298
11. Koga T., Ando E., Hirata A., et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 135 (2003) 188-193
12. Kimura A., Ando E., Fukushima M., et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch Ophthalmol 121 (2003) 351-356
13. da Cruz L., Chen F.K., Ahmado A., et al. RPE transplantation and its role in retinal disease. Prog Retin Eye Res 26 (2007) 598-635
14. Rufer F., and Roider J. General concepts in laser treatment for retinal vascular disease. In: Joussen A.M., Gardner T.W., Kirchhof B., and Ryan S.J. (Eds). Retinal Vascular Disease (2007), Springer-Verlag, Berlin 228-238
15. Futa R., Inada K., Nakashima H., et al. Familial amyloidotic polyneuropathy: ocular manifestations with clinicopathological observation. Jpn J Ophthalmol 28 (1984) 289-298
16. Silva-Araujo A.C., Tavares M.A., Cotta J.S., and Castro-Correia J.F. Aqueous outflow system in familial amyloidotic polyneuropathy, Portuguese type. Graefes Arch Clin Exp Ophthalmol 231 (1993) 131-135
17. Ando Y., Tanaka Y., Nakazato M., et al. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem Biophys Res Commun 211 (1995) 354-358
18. Ando Y., Terazaki H., Nakamura M., et al. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 77 (2004) 345-349
19. McLaurin J., Yang D., Yip C.M., and Fraser P.E. Review: modulating factors in amyloid-beta fibril formation. J Struct Biol 13 (2000) 259-270
20. Snow A.D., and Wight T.N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol Aging 10 (1989) 481-497